State Street Corp Sarepta Therapeutics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 4,141,793 shares of SRPT stock, worth $532 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,141,793
Previous 2,122,491
95.14%
Holding current value
$532 Million
Previous $275 Million
138.16%
% of portfolio
0.03%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.33 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.16 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$555 Million0.14% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$490 Million0.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$386 Million6.47% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.3B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...